A higher count of tumor specific CD8+ T cells has been correlated with increased survival in patients with HCC [76,77] and the enhanced infiltration of CD45RO+ T cells is considered a marker of improved clinical outcome in all types of solid tumors [78]. This evidence concerns the gene CD8A and neoplasm.